Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation

Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from para...

Full description

Saved in:
Bibliographic Details
Published inJournal of international medical research Vol. 42; no. 5; pp. 1110 - 1117
Main Authors Zou, JianYong, Bella, Amos Ela, Chen, ZhenGuang, Han, XiangQian, Su, ChunHua, Lei, YiYan, Luo, HongHe
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective A retrospective single-centre study to compare the clinical features of patients with lung adenocarcinoma with and without epidermal growth factor receptor (EGFR) mutations. Methods Pretreatment medical records of patients with lung adenocarcinoma were reviewed. DNA was extracted from paraffin wax-embedded tumour tissue for analysis of EGFR mutations. Malignant pleural effusion (MPE) was diagnosed by cytopathological testing of pleural fluid. Results EGFR mutations (19-Del and L858R) were recorded in 81/283 patients (28.6%). MPE was found in 42/283 patients (14.8%). In patients with stage IV disease, the frequency of EGFR mutations was higher in those with MPE than in those without MPE. EGFR mutations were independently associated with female sex, no history of smoking and presence of MPE. Conclusions There was a positive association between EGFR mutation and the presence of MPE. EGFR mutations may play an important role in the formation of MPE.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0300-0605
1473-2300
DOI:10.1177/0300060514539273